Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure*
Authors:
- Allan J. Md WalkeyAWAllan J. Md Walkey
- Todd W. Md RiceTRTodd W. Md Rice
- Jason KonterJKJason Konter
- Noriyuki OuchiNONoriyuki Ouchi
- Rei ShibataRSRei Shibata
- Kenneth WalshKWKenneth Walsh
- Bennett P. DeboisblancBDBennett P. Deboisblanc
- Ross SummerRSRoss Summer
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 38 (12) , 2329-2334
Abstract
Objective: Adiponectin, an anti-inflammatory cytokine produced by adipose tissue, has been shown to modulate survival in animal models of critical illness. We examined the association between plasma adiponectin and clinical outcomes in critically ill patients with acute respiratory failure. Design: Secondary analysis of a single-center, randomized controlled trial. Setting: Medical intensive care unit of a university-based, tertiary medical center. Patients: One hundred seventy-five subjects with acute respiratory failure enrolled in randomized, controlled pilot trial of Early versus Delayed Enternal Nutrition (EDEN pilot study). Interventions: None. Measurements and Main Results: Adiponectin measured within 48 hrs of respiratory failure (Apn1) was inversely correlated with body mass index (r = −0.25, p = .007) and was higher in females (median, 12.6 μg/mL; interquartile range, 7.6–17.1) than males (9.45 μg/mL; 6.2–14.2; p = .02). Adiponectin increased at day 6 (Apn1: 11.4 μg/mL [6.6–15.3] vs. Apn6: 14.1 μg/mL [10.3–18.6], p < .001). This increase was significant only in survivors (Δ adiponectin in survivors: 3.9 ± 6 μg/mL, n = 80, p < .001 vs. Δ in nonsurvivors: 1.69 ± 4.6 μg/mL, n = 14, p = .19). Higher Apn1 was significantly associated with 28-day mortality (odds ratio 1.59 per 5-μg/mL increase; 95% confidence interval 1.15–2.21; p = .006). No measured demographic, clinical, or cytokine covariates, including interleukin-6, interleukin-8, interleukin-10, interleukin-1β, interleukin-12, tumor necrosis factor-α, and interferon-γ, were confounders or effect modifiers of this association between adiponectin and mortality. Conclusions: Independent of measured covariates, increased plasma adiponectin levels measured within 48 hrs of respiratory failure are associated with mortality. This finding suggests that factors derived from adipose tissue play a role in modulating the response to critical illness.Keywords
This publication has 30 references indexed in Scilit:
- Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory PhenotypeJournal of Biological Chemistry, 2010
- What can adiponectin say about left ventricular function?Heart, 2009
- Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10Journal of Biological Chemistry, 2009
- Changes in serum adiponectin concentrations in critical illness: a preliminary investigationCritical Care, 2009
- Racial and ethnic disparities in mortality from acute lung injury*Critical Care Medicine, 2009
- Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortalityAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of internal medicine (1960), 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006